BioStem Technologies (BioStem Technologies) Cash And Cash Equivalents : $0.11 Mil (As of Sep. 2023)

View and export this data going back to 2008. Start your Free Trial

What is BioStem Technologies Cash And Cash Equivalents?

BioStem Technologies's quarterly cash and cash equivalents declined from Dec. 2022 ($0.77 Mil) to Mar. 2023 ($0.15 Mil) but then stayed the same from Mar. 2023 ($0.15 Mil) to Sep. 2023 ($0.11 Mil).

BioStem Technologies's annual cash and cash equivalents increased from Dec. 2020 ($0.10 Mil) to Dec. 2021 ($0.34 Mil) and increased from Dec. 2021 ($0.34 Mil) to Dec. 2022 ($0.77 Mil).

BioStem Technologies Cash And Cash Equivalents Historical Data

The historical data trend for BioStem Technologies's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioStem Technologies Cash And Cash Equivalents Chart

BioStem Technologies Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Cash And Cash Equivalents

Get a 7-Day Free Trial

1.18

0.14

0.10

0.34

0.77

BioStem Technologies Quarterly Data
	Sep15	Dec15	Dec16	Dec17	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Dec21	Mar22	Sep22	Dec22	Mar23	Sep23
Cash And Cash Equivalents	Get a 7-Day Free Trial															-	-	0.77	0.15	0.11

BioStem Technologies Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

BioStem Technologies (OTCPK:BSEM) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

BioStem Technologies Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of BioStem Technologies's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

BioStem Technologies (BioStem Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioStem Technologies Inc (OTCPK:BSEM) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

2836 Center Port Circle, Pompano Beach, FL, USA, 33064

Website

https://www.biostemtechnologies.com

BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. Its proprietary approach, Local MicroEnvironment Activation, uses combinations of Small Molecules, Cytokines, and Growth Factors to activate the microenvironment within the body to create communication for repair in the tissue. The Company offers a comprehensive portfolio of high-quality brands that are trademarked and include RHEO, AEON, OROPRO, VENDAJE, VENDAJE AC, and VENDAJE OPTIC.